Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Haisco Pharmaceutical Group Co Ltd (Haisco Pharmaceutical Group) is a pharmaceutical company that develops, manufactures and distributes pharmaceutical drugs. The company offers products such as narcotic analgesics, endocrine system drugs, enteral parenteral nutrition drugs, neuropsychiatric drugs, cardiovascular drugs, tumor related drugs, digestive liver disease drugs, and others. It also develops pipeline products in various therapeutic areas including central nervous system, oncology, respiratory, inflammatory and autoimmune, among others. The company utilizes Hi-BBP blood-brain barrier penetration platform, the Hi-PDT peptide drug technology platform, and the Hi-TPD targeted protein degradation platform. It operates in Liaoning, and Chengdu, China.Haisco Pharmaceutical Group is headquartered in Shannan, Tibet, China.
Haisco Pharmaceutical Group Co Ltd premium industry data and analytics
Products and Services
| Products |
|---|
| Narcotic Analgesics |
| Endocrine System Drugs |
| Enteral Parenteral Nutrition Drugs |
| XYZ |
| XYZ |
| XYZ |
Competitor Comparison
| Key Parameters | Haisco Pharmaceutical Group Co Ltd | Jiangsu Hengrui Pharmaceuticals Co Ltd | Zhangzhou Pien Tze Huang Pharmaceutical Co Ltd | Luye Pharma Group Ltd | CSPC Innovation Pharmaceutical Co Ltd |
|---|---|---|---|---|---|
| Headquarters | China | China | China | Hong Kong | China |
| City | Shannan | Lianyungang | Zhangzhou | Hong Kong City | Shijiazhuang |
| State/Province | Tibet | Jiangsu | Fujian | - | Hebei |
| No. of Employees | 5,597 | 20,602 | 2,886 | 5,221 | 2,369 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Wang Junmin | Chairman | Executive Board | 2010 | 58 |
| Yan Pangke | Director; General Manager | Executive Board | 2025 | 46 |
| Duan Peng | Chief Financial Officer | Senior Management | 2016 | 51 |
| Wang Meng | Secretary; Deputy General Manager | Senior Management | 2015 | 41 |
| Wang Ruibin | Deputy General Manager | Senior Management | 2025 | 64 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer